Biosyent Stock Fundamentals
| RX Stock | CAD 11.60 0.05 0.43% |
Biosyent fundamentals help investors to digest information that contributes to Biosyent's financial success or failures. It also enables traders to predict the movement of Biosyent Stock. The fundamental analysis module provides a way to measure Biosyent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biosyent stock.
At this time, Biosyent's Income Before Tax is fairly stable compared to the past year. Total Other Income Expense Net is likely to climb to about 1 M in 2024, whereas Selling And Marketing Expenses is likely to drop slightly above 4.3 M in 2024. Biosyent | Select Account or Indicator |
Biosyent Company Return On Equity Analysis
Biosyent's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Biosyent Return On Equity | 0.21 |
Most of Biosyent's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biosyent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Biosyent Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Biosyent is extremely important. It helps to project a fair market value of Biosyent Stock properly, considering its historical fundamentals such as Return On Equity. Since Biosyent's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biosyent's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biosyent's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Biosyent Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Biosyent has a Return On Equity of 0.2088. This is 100.87% lower than that of the Pharmaceuticals sector and 40.34% lower than that of the Health Care industry. The return on equity for all Canada stocks is 167.35% lower than that of the firm.
Biosyent Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biosyent's current stock value. Our valuation model uses many indicators to compare Biosyent value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biosyent competition to find correlations between indicators driving Biosyent's intrinsic value. More Info.Biosyent is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.62 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biosyent is roughly 1.62 . At this time, Biosyent's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biosyent's earnings, one of the primary drivers of an investment's value.Biosyent Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biosyent's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biosyent could also be used in its relative valuation, which is a method of valuing Biosyent by comparing valuation metrics of similar companies.Biosyent is currently under evaluation in return on equity category among its peers.
Biosyent Current Valuation Drivers
We derive many important indicators used in calculating different scores of Biosyent from analyzing Biosyent's financial statements. These drivers represent accounts that assess Biosyent's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biosyent's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 85.1M | 102.8M | 104.8M | 107.0M | 96.3M | 101.1M | |
| Enterprise Value | 73.5M | 84.2M | 88.3M | 100.2M | 90.2M | 94.7M |
Biosyent Fundamentals
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 115.91 M | ||||
| Shares Outstanding | 11.37 M | ||||
| Shares Owned By Insiders | 33.63 % | ||||
| Shares Owned By Institutions | 1.41 % | ||||
| Number Of Shares Shorted | 357 | ||||
| Price To Earning | 16.61 X | ||||
| Price To Book | 3.53 X | ||||
| Price To Sales | 3.90 X | ||||
| Revenue | 31.59 M | ||||
| Gross Profit | 22.86 M | ||||
| EBITDA | 7.99 M | ||||
| Net Income | 6.46 M | ||||
| Cash And Equivalents | 22.46 M | ||||
| Cash Per Share | 1.59 X | ||||
| Total Debt | 1.22 M | ||||
| Current Ratio | 10.10 X | ||||
| Book Value Per Share | 2.96 X | ||||
| Cash Flow From Operations | 5.83 M | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | 0.60 X | ||||
| Target Price | 11.75 | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 131.89 M | ||||
| Total Asset | 41.53 M | ||||
| Retained Earnings | 27.53 M | ||||
| Working Capital | 30.34 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 41.53 M |
About Biosyent Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biosyent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biosyent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biosyent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 134.5 K | 138 K | |
| Total Revenue | 31.6 M | 33.2 M | |
| Cost Of Revenue | 6.4 M | 6.8 M | |
| Stock Based Compensation To Revenue | 0.02 | 0.01 | |
| Sales General And Administrative To Revenue | 0.31 | 0.48 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 2.64 | 2.78 | |
| Ebit Per Revenue | 0.24 | 0.25 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.